U.S. REITS Stock News

What the recent move in BrightSpring Health Services (BTSG) means for investors BrightSpring Health Services (BTSG) has recently drawn attention after a strong run in the stock over the past month and past 3 months, prompting investors to reassess how its current valuation lines up with its fundamentals. See our latest analysis for BrightSpring Health Services. The recent strength in BrightSpring Health Services’ stock, with a 30 day share price return of 20.67% and a 90 day share price...

Why Warrior Met Coal is on investors’ radar Warrior Met Coal (HCC) has drawn attention after a 1 day gain of 0.34% contrasted with a month return of 5.56% and a past 3 months return of 1.36%. That short term pattern, together with a 1 year total return of 94.76% and multi year total returns reaching very large multiples of the starting point, has many investors reassessing where the stock currently sits. See our latest analysis for Warrior Met Coal. With the share price at $87.84, Warrior Met...

Halper Sadeh LLC is investigating e.l.f. Beauty (NYSE:ELF) for potential breaches of fiduciary duty by the company’s officers and directors. The review focuses on whether the board’s decisions have been consistent with obligations to shareholders and could have implications for corporate governance and oversight. The investigation may result in calls for board or policy changes, or potential financial relief, depending on its findings. e.l.f. Beauty operates in the color cosmetics and...

Masimo shareholders have officially approved the merger with Danaher (NYSE:DHR). The vote clears a key milestone for the acquisition and allows the deal process to move toward closing. The transaction is expected to expand Danaher's presence in diagnostics and medical technology once remaining conditions are met. For investors watching NYSE:DHR, this approval matters because it comes at a time when diagnostics, patient monitoring and broader medical technology are central to hospital and...

If you are trying to figure out whether Apellis Pharmaceuticals is attractively priced today, it helps to start with how the current market value lines up against different ways of estimating fair value. The stock last closed at US$41.01, with returns of 0.1% over 7 days, 0.8% over 30 days, 58.6% year to date and 130.3% over the past year, alongside 3 year and 5 year returns of 53.7% decline and 10.1% decline respectively. This gives a mixed picture for anyone thinking about entry or exit...

In late April 2026, Porch Group, Inc. reported first-quarter results showing sales of US$121.12 million, up from US$104.75 million a year earlier, while moving from net income of US$8.40 million to a net loss of US$4.71 million. At the same time, Porch Group shifted from earnings per share of US$0.08 to a loss of US$0.04, and followed up with non-deal roadshow presentations in Boston and New York to explain its evolving business model to investors. With first-quarter revenue growth...

Recent performance snapshot for Federal Home Loan Mortgage Federal Home Loan Mortgage (FMCC) has drawn attention after a 1-month return of about 26%, contrasting with a year-to-date decline of roughly 31% and a 3-month decline of nearly 3%. See our latest analysis for Federal Home Loan Mortgage. The share price has recently swung higher, with a 30 day share price return of about 26% from a last close of US$7.14. However, this follows a weaker year to date share price return and contrasts with...

Vistra (VST) has wrapped up FY 2025 with fourth quarter revenue of US$4.6b, Basic EPS of US$0.55 and net income of US$185m, rounding out a trailing twelve month picture that totals US$17.7b in revenue, Basic EPS of US$2.22 and net income of US$752m. Over recent quarters, reported revenue has moved from US$4.0b in Q4 2024 to US$4.6b in Q4 2025, while quarterly Basic EPS has ranged from US$1.16 in Q4 2024 to US$0.55 most recently, setting up a results season where investors are weighing...

Earlier this week, enGene Therapeutics reported interim Phase 2 LEGEND trial results for its bladder cancer gene therapy detalimogene voraplasmid, revealing a 54% complete response rate but weaker 12‑month durability than previously expected, alongside generally manageable side effects and low disease progression. The mixed efficacy profile has triggered analyst downgrades and shareholder-rights investigations, highlighting how a single data update can rapidly reshape perceptions of a...

Why Enpro's updated 2026 guidance is on investors’ radar Enpro (NPO) raised its full-year 2026 revenue growth guidance to a range of 10% to 14% after reporting first-quarter sales of US$303 million and net income of US$27.4 million, both above last year. See our latest analysis for Enpro. Following the upgraded 2026 outlook, the stock has had a strong run, with a 30 day share price return of 18.13% and a year to date share price return of 37.20%. The 1 year total shareholder return of 67.81%...

Earlier this week, Teradata Corporation reported Q1 2026 results with revenue of US$444 million and GAAP diluted EPS of US$3.47, lifted by a very large US$480 million settlement from SAP and solid recurring revenue growth. Teradata also unveiled its new Autonomous Knowledge Platform, aiming to unify AI, analytics, and data across cloud and on-premises environments to support governed, production-scale AI agents for large enterprises. We’ll now examine how the launch of the Autonomous...

UFP Industries (UFPI) is back in focus after reporting a year over year drop in first quarter 2026 sales and profit, as softer demand across retail, packaging and construction weighs on investor sentiment. See our latest analysis for UFP Industries. The share price has been under pressure, with a 90 day share price return of 26.56% decline and a 1 year total shareholder return of 13.59% decline. This signals fading momentum, even as acquisitions and buybacks continue in an effort to reshape...

Texas Roadhouse (TXRH) FY 2025 earnings at a glance Texas Roadhouse (TXRH) has wrapped up FY 2025 with fourth quarter revenue of US$1.5 billion and basic EPS of US$1.28, while full-year trailing twelve month revenue came in at US$5.9 billion and EPS at US$6.11. The company reported quarterly revenue moving from US$1.44 billion in Q4 2024 to US$1.48 billion in Q4 2025, alongside basic EPS shifting from US$1.74 to US$1.28. This sets the backdrop for how investors may assess the latest results...

If you are wondering whether Planet Labs PBC at around US$35.24 is priced attractively or already baking in big expectations, it helps to step back and look at how the stock has been behaving and what that might imply about value. The share price is around US$35.24, with a 4.7% decline over the last week, roughly flat at 0.2% over the past month, a 72.7% gain year to date, and a very large rise over the past year that is close to 9x, as well as very strong multi year returns. These moves...

In early May 2026, Hagerty, Inc. reported first-quarter results showing sales of US$265.29 million, total revenue of US$311.83 million, and a net loss of US$6.52 million, compared with net income in the same period a year earlier. The company also reaffirmed its 2026 guidance, explaining that an expected 11% to 12% revenue decline and a US$41 million to US$51 million net loss largely reflect the accounting impact of its Markel Fronting Arrangement and control of the Essentia book of...

Investors may be wondering if Hasbro at around US$97.39 is still offering value after a strong run, or if most of the opportunity has already been priced in. The stock has posted returns of 1.6% over the last 7 days, 8.9% over 30 days, 17.4% year to date, 63.3% over 1 year, 82.9% over 3 years and 22.6% over 5 years, which puts recent performance firmly on investors' radar. Recent headlines have focused on Hasbro's ongoing efforts to sharpen its portfolio and keep its brands relevant, which...

NiSource (NYSE:NI) announced new and expanded partnerships with Amazon and Alphabet that are expected to support $1.4 billion in customer savings over 15 years. Alongside these partnerships, the company updated its long term adjusted EPS growth outlook to a range of 9% to 10% through 2033. For investors watching utilities, NiSource stands out with a current share price of $47.02 and a 5 year return of 115.2%. The stock has also returned 21.9% over the past year and 83.7% over 3 years,...

Brookfield Business Corporation reported first-quarter 2026 results, with sales of US$6,436 million and net income of US$40 million, both lower than a year earlier. The simultaneous decline in revenue and profit highlights pressure on the company’s operating performance at the start of 2026. We’ll now consider how this first-quarter downturn in revenue and earnings shapes Brookfield Business Partners’ broader investment narrative. The latest GPUs need a type of rare earth metal called...

Geopolitical tensions and higher oil prices are pushing up ocean freight costs for Columbia Sportswear, raising questions about future gross margins. Renewed U.S. Iran frictions are contributing to more expensive international shipping, which could affect sourcing and distribution for Columbia's global business. These supply chain pressures come as investors focus on how apparel companies handle external cost shocks alongside consumer demand trends. Columbia Sportswear (NasdaqGS:COLM) is...

eToro Group (NasdaqGS:ETOR) CEO Yoni Assia has outlined a vision for capital markets built around 24/7 crypto trading and always-on access. In recent interviews, Assia described a future where autonomous, AI-driven agents participate in markets continuously across assets and platforms. The comments highlight eToro’s focus on AI-managed investment strategies and a machine-led trading framework that does not rely on traditional market hours. eToro runs a multi asset trading and investment...

In the first quarter of 2026, Medical Properties Trust reported revenue of US$252.07 million and net income of US$32.83 million, reversing a prior-year net loss and lifting earnings per share from a loss of US$0.20 to a profit of US$0.05. This shift from loss to profit, alongside higher sales versus a year earlier, suggests management’s efforts to stabilize operations and rental income are beginning to show up in the company’s financial results. With Medical Properties Trust returning to...

This article examines whether Primo Brands, trading at around US$22.24, currently represents value or risk by exploring what the share price might be implying. The stock has returned 9.1% over the last 7 days, 21.3% over the last 30 days and 37.4% year to date, while the 1 year return reflects a 29.8% decline and the 3 and 5 year returns are 69.8% and 48.4% respectively. Recent market interest in Primo Brands appears tied to broader investor attention on beverage companies listed in the US...

Sphere Entertainment: recent performance overview Sphere Entertainment (SPHR) has been on many investors’ radars after a very large 1 year total return of 333%, alongside a past 3 months return of 46.7% and a 1 month gain of 10%. Those moves sit against annual revenue of US$1.33b and net income of US$113.77m, with revenue growth of 2.5% and annual net income growth indicating a 74.6% decline, creating a mixed backdrop for further analysis. See our latest analysis for Sphere Entertainment. The...

Booz Allen Hamilton (NYSE:BAH) has appointed former U.S. Army Chief Information Officer Leonel Garciga as Senior Executive Advisor. Garciga is expected to focus on artificial intelligence and defense technology initiatives across the firm’s government-focused business. The appointment centers on AI integration and large-scale technology transformation for defense clients. Booz Allen Hamilton, through its consulting and technology services, is deeply tied to U.S. federal defense and...